ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
University of British Columbia at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
University of British Columbia takes part in 11 sessions at ASHI 2026 in Montréal. Its sessions focus on donor-derived cell-free DNA testing, including sample stability and decentralized testing, and on antibody-mediated rejection with and without donor-specific HLA antibodies. It also covers a serum lipid signature that spots rejection without a biopsy, real-world AI in transplantation, and blood group genotyping with Rbceq2.
| Organization | ASHI 2026 Attendance |
|---|---|
University of British Columbia Vancouver, BC | |
Public research university with a faculty of medicine affiliated with teaching hospitals in Vancouver and across British Columbia. | Industry Tue Oct 27 12:30pm–1:25pm Redefining Histocompatibility: Faster HLA Typing, Deeper Ab Insights HLA typing, sequencing and genotypingHLA antibodies, crossmatching and eplets Talk Tue Oct 27 2:30pm–2:45pm A Novel Serum Lipid Signature Identifies Antibody-Mediated Rejection Without Biopsy Solid organ transplantationChimerism, cell-free DNA and post-transplant monitoring Session Wed Oct 28 10:30am–12:00pm Plenary 2: Real World Implications of Deploying AI in Transplantation Bioinformatics, AI and risk modeling Talk Wed Oct 28 2:45pm–3:15pm Pre-analytic Considerations and the Analytic Validity of Decentralized Donor-Derived Cell-Free DNA Testing Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Talk Thu Oct 29 10:00am–10:15am Talk Thu Oct 29 1:10pm–1:40pm "Classical" Antibody-Mediated Rejection (ABMR) with Detectable Donor-Specific HLA Antibodies Solid organ transplantationHLA antibodies, crossmatching and eplets Talk Thu Oct 29 2:25pm–2:40pm Impact of Pre-Analytic Sample Stability on Downstream Donor-Derived Cell Free DNA Results Chimerism, cell-free DNA and post-transplant monitoringLab quality, accreditation and operations Session Thu Oct 29 4:15pm–5:45pm Workshop 5: Transplant Balancing Act: Navigating Infection and Rejection in the Era of the Microbiome Solid organ transplantation Session Fri Oct 30 9:30am–10:30am ASHI/CST Joint Session 5: cfDNA Diagnostics Utility in the Era of "Liquid Biopsy". Promises and Challenges in Transplantation Chimerism, cell-free DNA and post-transplant monitoringSolid organ transplantation Session Fri Oct 30 10:30am–12:00pm ASHI/CST Joint Session 6: Desensitization in Solid Organ Transplantation: From immunologic challenge to new opportunities Solid organ transplantationHLA antibodies, crossmatching and eplets Poster Evaluation of Rbceq2 for High Resolution Genotyping of ABO And Other Relevant Blood Group Genes in Transplantation HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling |
Find decision makers at University of British Columbia
Tell us what you sell and we’ll find the people at University of British Columbia most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction